Milestone Prescription Price Drops and the CTE Diagnostic Puzzle
Key Takeaways
- Prescription price drops reached a historic milestone recently, with national prices falling 3.1% over the past year—the steepest annual decline recorded since 1963.
- The recent drop in prescription price drops is being driven by a combination of factors, including increased generic competition, GLP-1 market pressures, and the impact of the Inflation Reduction Act.
- Despite national indices showing significant prescription price drops, patients may not always experience these savings immediately at the local pharmacy counter due to complex PBM and insurance structures.
- Recent medical literature highlights a split between two studies investigating whether chronic traumatic encephalopathy (CTE) can be accurately diagnosed in living patients.
- Healthcare professionals also need to stay updated on emerging clinical discussions regarding the limitations of BMI compared to waist size and the latest C. diff treatment updates.
Friday, August 21, 2026
In today's episode, Dr. Will Flanary (@drglaucomflecken) & Eva Johnson cover a historic drop in prescription drug prices. Prices fell 3.1% over the past year, the steepest annual decline since 1963, and the anchors unpack what is actually driving it from generics to GLP-1 competition to the Inflation Reduction Act. They also break down why the national index does not always match what patients pay at the pharmacy counter. Plus: a split between two studies on whether CTE can be diagnosed in living patients, and more.
Coverage Timeline:
(00:00) Intro
(01:04) Drug Prices Drop
(04:25) Diagnosing CTE in Living Patients
(08:18) Waist Size vs BMI
(09:26) C. Diff Treatment Updates
Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit https://www.medlinespod.com or email medlines@human-content.com.
Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources
Medlines is a Human Content Production
Frequently Asked Questions
What caused the historic prescription price drops?
The recent prescription price drops are primarily driven by a rise in generic alternatives, increasing competition among GLP-1 medications, and the implementation of the Inflation Reduction Act.
Why don't patients always see prescription price drops at the pharmacy?
While national indexes show a 3.1% decline in drug prices, individual out-of-pocket costs at the pharmacy counter can still vary due to insurance formularies, deductibles, and pharmacy benefit manager pricing structures.
Can CTE be diagnosed in living patients?
Recent research reveals a split between two major studies regarding the reliability and accuracy of diagnosing chronic traumatic encephalopathy (CTE) in living patients.